MedTrace Logo

Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes

NCT03056872 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-05-31

No results posted yet for this study

Summary

Alcohol dependence is among the most common and costly public health problems affecting the nation. Among individuals with alcohol use disorder (AUD), those with (vs. without) a co-occurring anxiety disorder (AnxD) are as much as twice as likely to relapse in the months following AUD treatment. Dysregulation of biological stress-mood systems predict and correlate with AUD relapse and AnxD symptomatology. In contrast, stress system re-regulation correlates with improved AUD treatment outcomes but has not been examined with respect to AUD recovery and relapse in co-occurring AUD+AnxD.

Conditions

  • Alcohol Use Disorder
  • Anxiety Disorder/Anxiety State
  • Stress Disorder
  • Hypothalamic Pituitary Adrenal
  • Drinking to Cope

Sponsors & Collaborators

Principal Investigators

  • Justin Anker, PhD · University of Minnesota

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-05
Primary Completion
2023-05-12
Completion
2023-05-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03056872 on ClinicalTrials.gov